Hui-Wen Lo, Ph.D. Professor and Director of Metastatic Brain Tumor Program

About Hui-Wen Lo, Ph.D. Professor and Director of Metastatic Brain Tumor Program

Hui-Wen Lo, Ph.D. Professor and Director of Metastatic Brain Tumor Program, With an exceptional h-index of 49 and a recent h-index of 39 (since 2020), a distinguished researcher at Wake Forest University, specializes in the field of molecular and cell biology, cancer, experimental therapeutics, drug development.

His recent articles reflect a diverse array of research interests and contributions to the field:

Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis

Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment

Patterns of Failure Outcomes for Combination of Stereotactic Radiosurgery and Immunotherapy for Melanoma Brain Metastases

Tumor suppressor candidate 2 (TUSC2): discovery, functions, and cancer therapy

Anti-CD47 immunotherapy as a therapeutic strategy for the treatment of breast cancer brain metastasis

Intracellular miR-1290 promotes breast cancer stemness in HER2-enriched and triple-negative breast cancer

Dual targeting of JAK2 and TrkA inhibits breast cancer cell stemness, enhances apoptosis, and delays tumor growth of triple-negative and HER2-enriched breast cancers

Investigating TUSC2 for its tumor suppressive functions in glioblastoma and its role in gliomagenesis

Hui-Wen Lo, Ph.D. Professor and Director of Metastatic Brain Tumor Program Information

University

Position

School of Medicine

Citations(all)

9976

Citations(since 2020)

4429

Cited By

7203

hIndex(all)

49

hIndex(since 2020)

39

i10Index(all)

80

i10Index(since 2020)

70

Email

University Profile Page

Google Scholar

Hui-Wen Lo, Ph.D. Professor and Director of Metastatic Brain Tumor Program Skills & Research Interests

molecular and cell biology

cancer

experimental therapeutics

drug development

Top articles of Hui-Wen Lo, Ph.D. Professor and Director of Metastatic Brain Tumor Program

Title

Journal

Author(s)

Publication Date

Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis

Oncogene

Daniel Doheny

Sherona Sirkisoon

Richard L Carpenter

Noah Reeve Aguayo

Angelina T Regua

...

2024/4/27

Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment

Communications Biology

Qianqian Song

Jimmy Ruiz

Fei Xing

Hui-Wen Lo

Lou Craddock

...

2023/7/21

Patterns of Failure Outcomes for Combination of Stereotactic Radiosurgery and Immunotherapy for Melanoma Brain Metastases

Neurosurgery Practice

Mohammed Abdulhaleem

Hannah Johnston

Ralph D'Agostino Jr

Claire Lanier

Christina K Cramer

...

2023/3/1

Tumor suppressor candidate 2 (TUSC2): discovery, functions, and cancer therapy

Austin Arrigo

Angelina T Regua

Mariana K Najjar

Hui-Wen Lo

2023/4/25

Anti-CD47 immunotherapy as a therapeutic strategy for the treatment of breast cancer brain metastasis

bioRxiv

Jessica D Mackert

Elizabeth R Stirling

Adam S Wilson

Brian Westwood

Dawen Zhao

...

2023

Intracellular miR-1290 promotes breast cancer stemness in HER2-enriched and triple-negative breast cancer

Cancer Research

Grace L Wong

Mariana Najjar

Yoshua Esquenazi

Nitin Tandon

Angelina T Regua

...

2023/4/4

Dual targeting of JAK2 and TrkA inhibits breast cancer cell stemness, enhances apoptosis, and delays tumor growth of triple-negative and HER2-enriched breast cancers

Cancer Research

Angelina T Regua

Mariana K Najjar

Grace L Wong

Sara G Manore

Austin Arrigo

...

2023/4/4

Investigating TUSC2 for its tumor suppressive functions in glioblastoma and its role in gliomagenesis

Cancer Research

Austin Arrigo

Mariana Najjar

Angelina Regua

Hui-Wen Lo

2023/4/4

Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases

Frontiers in Oncology

Mohammed Abdulhaleem

John C Hunting

Yuezhu Wang

Margaret R Smith

Ralph D’jr Agostino

...

2023/11/7

Five-year survivors from brain metastases treated with stereotactic radiosurgery: Biology, improving treatments, or just plain luck?

Neuro-Oncology Practice

Jane B Pearce

Fang-Chi Hsu

Claire M Lanier

Christina K Cramer

Jimmy Ruiz

...

2023/4/1

hDirect-MAP: projection-free single-cell modeling of response to checkpoint immunotherapy

Briefings in Bioinformatics

Yong Lu

Gang Xue

Ningbo Zheng

Kun Han

Wenzhong Yang

...

2022/3

TrkA and JAK2-STAT3 pathway crosstalk promotes breast cancer stem cells in HER2-enriched and triple-negative breast cancers

Cancer Research

Angelina T Regua

Dongqin Zhu

Daniel L Doheny

Grace L Wong

Sara G Manore

...

2022/6/15

RET signaling pathway and RET inhibitors in human cancer

Angelina T Regua

Mariana Najjar

Hui-Wen Lo

2022/7/25

5 Year Survivors from Brain Metastases Treated with Stereotactic Radiosurgery: Biology, Improving Treatments or Just Plain Luck?

International Journal of Radiation Oncology, Biology, Physics

JB Pearce

FC Hsu

CM Lanier

CK Cramer

J Ruiz

...

2022/11/1

Correction: upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells

Oncogene

X Cao

J Geradts

MW Dewhirst

H-W Lo

2022/2/18

NEDD4 degrades TUSC2 to promote glioblastoma progression

Cancer letters

Tadas K Rimkus

Austin B Arrigo

Dongqin Zhu

Richard L Carpenter

Sherona Sirkisoon

...

2022/4/10

TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospects

Kojo Agyemang

Allan M Johansen

Grayson W Barker

Michael J Pennison

Kimberly Sheffield

...

2022/7/19

STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges

Grace L Wong

Sara G Manore

Daniel L Doheny

Hui-Wen Lo

2022/11/1

Upfront immunotherapy leads to lower brain metastasis velocity in patients undergoing stereotactic radiosurgery for brain metastases

Journal of Radiosurgery and SBRT

Mohammed Abdulhaleem

Emmanuel Scott

Hannah Johnston

Scott Isom

Claire Lanier

...

2022

Brain metastasis prognostic nomograms and brain metastasis velocity: a narrative review

Mohammed Abdulhaleem

Jimmy Ruiz

Christina Cramer

Fei Xing

Hui Wen Lo

...

2022/4

See List of Professors in Hui-Wen Lo, Ph.D. Professor and Director of Metastatic Brain Tumor Program University(Wake Forest University)